Documentos relacionados

1. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on ß654-Thalassemia.
2. A synonymous variant is unmasked in thalassaemia.
3. When a synonymous mutation breaks the silence in a thalassaemia patient.
4. Efficacy and Safety of Gene Therapy for ß-Thalassemia.
5. Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) ß-thalassemia mutation.
6. CRISPR/Cas9, a promising approach for the treatment of ß-thalassemia: a systematic review.
7. The continuing global challenges of treating patients with beta-thalassemia.
8. ß-Thalassemia Trait Caused by <i>SUPT5H</i> Defects: Another Case Report.
9. Safety and efficacy of peripheral blood stem cells collection in healthy children and pediatric patients with thalassemia major weighing 20 kg or less.
10. Defining curative endpoints for transfusion-dependent ß-thalassemia in the era of gene therapy and gene editing.